GWM
TMDX icon

Geneos Wealth Management’s Transmedics TMDX Stock Holding History

Geneos Wealth Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.05M Buy
+30,635
New +$4M 0.07% 287
2025
Q2 		– Sell
-8
Closed -$538 – 3228
2025
Q1 		$538 Buy
+8
New +$550 ﹤0.01% 3069
2024
Q4 		– Sell
-49
Closed -$7.69K – 2963
2024
Q3 		$7.69K Buy
+49
New +$7.55K ﹤0.01% 1928

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Geneos Wealth Management's TMDX Position: Q1 2026 in Review

Geneos Wealth Management opened a new position in Transmedics (TMDX) in Q1 2026: 30,635 shares worth $3.05M. The stake represents 0.07% of the portfolio and ranks #287 among its holdings. This is a return to the name: Geneos Wealth Management previously reported a position in TMDX as recently as Q1 2025.

Geneos Wealth Management first reported a position in TMDX in Q3 2024 and has held it in 3 quarters since. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Geneos Wealth Management held 30,635 shares of Transmedics worth $3.05M as of Q1 2026.
  • Transmedics was a new Geneos Wealth Management position in Q1 2026.
  • Transmedics made up 0.07% of Geneos Wealth Management's portfolio in Q1 2026, its #287 holding.
  • Geneos Wealth Management first reported a position in Transmedics in Q3 2024 and has held it in 3 quarters since.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.